Your browser doesn't support javascript.
loading
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; Giudicelli-Lett, Heloïse; Nicoara-Farcau, Oana; Rajoriya, Neil; Goel, Ashish; Raymenants, Karlien; Hillaire, Sophie; Crespo, Gonzalo; Téllez, Luis; Elkrief, Laure; Fondevila, Constantino; Orts, Lara; Nery, Filipe; Shukla, Akash; Larrue, Hélène; Fundora, Yiliam; Degroote, Helena; Aguilera, Victoria; LLop, Elba; Turco, Laura; Indulti, Federica; Gioia, Stefania; Tosetti, Giulia; Bitto, Niccolò; Becchetti, Chiara; Alvarado, Edilmar; Roig, Cristina; Diaz, Raquel; Praktiknjo, Michael; Konicek, Anna-Lena; Soy, Guillem; Olivas, Pol; Fortea, José Ignacio; Masnou, Helena; Puente, Ángela; Ardèvol, Alba; Álvarez-Navascués, Carmen; Romero, Marta; Scheiner, Bernhard; Semmler, Georg; Mandorfer, Mattias; Damião, Filipe; Baiges, Anna; Turon, Fanny; Simón-Talero, Macarena; González-Alayón, Carlos; Díaz, Alba; García-Criado, Ángeles; de Gottardi, Andrea; Reverter, Enric.
Afiliação
  • Magaz M; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Giudicelli-Lett H; CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas).
  • Nicoara-Farcau O; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Rajoriya N; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Goel A; Service d'Hépatologie, Centre de Référence des Maladies Vasculaires du Foie, DHU Unity, Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, AP-HP, Clichy, France.
  • Raymenants K; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Hillaire S; CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas).
  • Crespo G; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Téllez L; Regional Institute of Gastroenterology and Hepatology "Octavian Fodor," Hepatology Department and "Iuliu Hatieganu" University of Medicine and Pharmacy, 3rd Medical Clinic, Cluj-Napoca, Romania.
  • Elkrief L; The Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Fondevila C; The Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Orts L; Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Leuven, Belgium.
  • Nery F; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Shukla A; Service d'Hépatologie, Centre de Référence des Maladies Vasculaires du Foie, DHU Unity, Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, AP-HP, Clichy, France.
  • Larrue H; Liver Transplantation Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Fundora Y; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Degroote H; Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, IRYCIS, CIBERehd, Universidad de Alcalá, Madrid, Spain.
  • Aguilera V; Service d'Hépato-Gastroentérologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Service d'Hépato-Gastroentérologie, CHU de Tours, France.
  • LLop E; Université de Paris, Centre de recherche sur l'inflammation, Inserm, U1149, CNRS, ERL8252, Paris, France.
  • Turco L; Department of Surgery, Division of Hepatobiliary and General Surgery, Institut de Malalties Digestives I Metabòliques (IMDiM), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Indulti F; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Gioia S; CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas).
  • Tosetti G; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • Bitto N; Liver Unit, Centro Hospitalar do Porto, Hospital Sto Antonio, Porto, Portugal.
  • Becchetti C; Department of Gastroenterology, Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India.
  • Alvarado E; Department of Hepatology, Rangueil Hospital, CHU Toulouse, University Paul Sabatier of Toulouse, Toulouse, France.
  • Roig C; Department of Surgery, Division of Hepatobiliary and General Surgery, Institut de Malalties Digestives I Metabòliques (IMDiM), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Diaz R; Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium.
  • Praktiknjo M; Liver Transplantation and Hepatology Unit, Hospital Universitari i Politécnic La Fe, Valencia, Spain.
  • Konicek AL; CIBERehd (Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Valencia Spain), Instituto de Salud Carlos III.
  • Soy G; Liver Unit, Hospital U, Puerta de Hierro, Universidad Autònoma de Madrid, CIBERehd, Madrid, Spain.
  • Olivas P; Department of Gastroenterology and Hepatology, University of Modena & Reggio Emilia and Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Fortea JI; Department of Gastroenterology and Hepatology, University of Modena & Reggio Emilia and Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Masnou H; Department of Gastroenterology and Hepatology, Centre for the Diagnosis and Treatment of Portal Hypertension, "Sapienza" University of Rome, Rome, Italy.
  • Puente Á; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, CRC "A.M.and A.Miglaivacca" Center for Liver Disease, Milan, Italy.
  • Ardèvol A; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, CRC "A.M.and A.Miglaivacca" Center for Liver Disease, Milan, Italy.
  • Álvarez-Navascués C; Hepatology Group, Swiss Liver Center, University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, Bern, Switzerland.
  • Romero M; Liver Unit, Department of Gastroenterology Hospital Sant Pau, Barcelona, Autonomous University, Barcelona, Spain.
  • Scheiner B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
  • Semmler G; Liver Unit, Department of Gastroenterology Hospital Sant Pau, Barcelona, Autonomous University, Barcelona, Spain.
  • Mandorfer M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
  • Damião F; Department of Gastroenterology and Hepatology, University Gregorio Marañón Hospital, liSGM, CIBERehd, Barcelona, Spain.
  • Baiges A; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Turon F; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Simón-Talero M; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • González-Alayón C; CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas).
  • Díaz A; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
  • García-Criado Á; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • de Gottardi A; CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas).
  • Reverter E; Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver).
Transplantation ; 107(6): 1330-1340, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36479977
ABSTRACT

BACKGROUND:

Porto-sinusoidal vascular liver disorder (PSVD) is a rare disease that occasionally requires liver transplantation (LT), despite usually presenting preserved liver function. There remains a paucity of data pertaining to LT in PSVD. The aim was to identify features associated with post-LT outcomes in PSVD.

METHODS:

Retrospective multicentre study of 79 patients who received LT for PSVD.

RESULTS:

Median post-LT follow-up was 37 (range 1-261) mo. Refractory ascites 24 (30%), hepatic encephalopathy 16 (20%), and hepatopulmonary syndrome 13 (16.3%) were the most frequent indications for LT. Hepatocellular carcinoma was the indication in only 2 patients. Twenty-four patients died, 7 due to liver and 17 to non-liver related causes. Post-LT survival was 82.2%, 80.7%, and 68.6% at 1, 2, and 5 y, respectively. Post-LT survival was significantly better in patients without (n = 58) than in those with a persistent severe PSVD-associated condition (n = 21). Pre-LT hyperbilirubinemia levels and creatinine >100 µmol/L were also independently associated with poor survival. Six patients (7.6%) required a second LT. Recurrence of PSVD was confirmed by liver biopsy in only 1 patient and in 3 further patients it was likely.

CONCLUSIONS:

LT in PSVD is associated with an acceptable outcome in the absence of associated severe conditions. However, persistence of a severe associated condition, pre-LT high bilirubin levels, or creatinine >100 µmol/L impact outcome, and these are features that should be considered when evaluating PSVD patients for LT. PSVD recurrence is possible after LT and needs to be explored, at least, in cases of posttransplant portal hypertension.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Transplante de Fígado / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Transplante de Fígado / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article